Re: 'efficacy and safety of selective serotonin reuptake inhibitors in COVID-19 management: a systematic review and meta-analysis' by Deng et al.

Zeng, Guangting; Liu, Jing; Liu, Shulan

Re: 'efficacy and safety of selective serotonin reuptake inhibitors in COVID-19 management: a systematic review and meta-analysis' by Deng et al.

Zeng, Guangting; Liu, Jing; Liu, Shulan.

Zeng G; Department of Pharmacy, The First People's Hospital of Chenzhou, Xiangnan University, Chenzhou, People's Republic of China. Electronic address: 1090651185@qq.com.
Liu J; Department of Pharmacy, The First People's Hospital of Chenzhou, Xiangnan University, Chenzhou, People's Republic of China.
Liu S; Department of Pharmacy, The First People's Hospital of Chenzhou, Xiangnan University, Chenzhou, People's Republic of China.

Clin Microbiol Infect ; 29(6): 814, 2023 06.

Artículo en Inglés | MEDLINE | ID: covidwho-2288401

Asunto(s)

COVID-19; Inhibidores Selectivos de la Recaptación de Serotonina; Humanos; Inhibidores Selectivos de la Recaptación de Serotonina/efectos adversos

Palabras clave

COVID-19; Efficacy; Fluvoxamine; Safety; Selective serotonin reuptake inhibitors

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: Disponible Colección: Bases de datos internacionales Base de datos: MEDLINE Asunto principal: Inhibidores Selectivos de la Recaptación de Serotonina / COVID-19 Tipo de estudio: Revisiones / Revisión sistemática/Meta análisis Límite: Humanos Idioma: Inglés Revista: Clin Microbiol Infect Asunto de la revista: Enfermedades Transmisibles / Microbiologia Año: 2023 Tipo del documento: Artículo

Similares

MEDLINE

LILACS

LIS

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google